Gregory L Weaver is Chief Financial Officer of Altimmune, Inc.. Currently has a direct ownership of 23,078 shares of ALT, which is worth approximately $96,235. The most recent transaction as insider was on Nov 11, 2025, when has been sold 5,672 shares (Common Stock, par value $0.0001) at a price of $4.28 per share, resulting in proceeds of $24,276. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1K
130.78% 3M change
n/a 12M change
Total Value Held $96,235

GREGORY L WEAVER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2025
SELL
Payment of exercise price or tax liability
$24,276 $4.28 p/Share
5,672 Reduced 19.73%
23,078 Common Stock, par valu...
Nov 11 2025
BUY
Exercise of conversion of derivative security
-
18,750 Added 39.47%
28,750 Common Stock, par valu...
Mar 13 2025
BUY
Open market or private purchase
$52,000 $5.2 p/Share
10,000 Added 50.0%
10,000 Common Stock, par valu...

Also insider at

ATAI
ATAI Life Sciences N.V. Healthcare
ATOS
ATOSSA THERAPEUTICS, INC. Healthcare
GLW

Gregory L Weaver

Chief Financial Officer
Berlin, 2M

Track Institutional and Insider Activities on ALT

Follow Altimmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALT shares.

Notify only if

Insider Trading

Get notified when an Altimmune, Inc. insider buys or sells ALT shares.

Notify only if

News

Receive news related to Altimmune, Inc.

Track Activities on ALT